Gujarat Themis Biosyn Ltd

NSE: GUJTHEM BSE: 506879

₹355.60

(0.18%)

Mon, 25 May 2026, 06:43 am

MTF 5xInvest in Gujarat Themis Biosyn Ltd with 5x Leverage Buy with MTF

Market Cap38.63B

PE Ratio81.08

Dividend0.19

Health Technology

Pharmaceuticals: Major

24.5K

Gujarat Themis Biosyn News

GTBL Acquires MicroBiopharm Japan for JPY 21.5 Billion

Gujarat Themis Biosyn enters definitive agreement to acquire 100% of MicroBiopharm Japan Co., Ltd. for JPY 21.5 Billion (~INR 1,300 Crores), with deal closure expected in Q2 FY2027.

22 May 2026

companies

Gujarat Themis sets up Japan unit

Gujarat Themis Biosyn incorporated a wholly owned subsidiary, Themis Biosyn Japan Limited, on May 19, 2026.

19 May 2026

companies

Gujarat Themis Biosyn Board Meet on May 25 for FY26 Results

Gujarat Themis Biosyn has scheduled a Board of Directors meeting on May 25, 2026, to approve audited financial results for Q4 and FY26, and consider dividend recommendation.

19 May 2026

companies

Gujarat Themis Biosyn Postal Ballot Notice

Gujarat Themis Biosyn Limited has announced a postal ballot for special resolutions regarding borrowing limits and loan provisions. E-voting commences on 6th May 2026.

06 May 2026

companies

Gujarat Themis Biosyn Releases Investor Presentation

Gujarat Themis Biosyn Limited submits investor presentation to stock exchanges regarding €158 million acquisition of Sanofi's global anti-TB and anti-infective portfolio under Regulation 30.

25 Apr 2026

companies

Showing 1–5 of 25

Rows per page:

Market Current News

C K K RETAIL MART LIMITED

CKK Retail Board Approves IPO Terms Variation

CKK Retail Mart Limited's board approved variations in IPO terms and extending fund usage period. Shareholder approval via postal ballot is sought for these changes.

23 May 2026

ipo

Gulf States Urge Trump to Avoid Renewed Iran Conflict

UAE, Saudi Arabia, and Qatar are collaborating to urge Trump against renewing conflict with Iran, signaling a unified Gulf diplomatic stance on regional security.

22 May 2026

global

M R Maniveni Foods Subscription Update

M R Maniveni Foods IPO subscribed 1.08 times. QIBs subscribed 1x, while Non-Institutional Buyers(bHNI) led with 2.45x.

22 May 2026

ipo

Bio Medica Subscription Data

Bio Medica Laboratories' IPO was subscribed 1.05 times overall. QIBs led with 15.94x, while retail and other categories saw lower demand.

22 May 2026

ipo

LME Copper Inventory Demand Hits Highest Since 2013

Demand for LME copper inventories has risen to its highest level since 2013, marking a significant development in the global copper market.

22 May 2026

commodities

Showing 1–5 of 93750

Rows per page: